EUVIMEDEUVIMED entdecken
Leserbrief

Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries

Poppy Sullivan iD, Sabthagi Sivathasan iD

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15352 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Poppy Sullivan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Barts and the London, School of Medicine and Dentistry (QMUL), London, UK. Hauptthemen laut MEDLINE: Misoprostol, Abortifacient Agents, Abortion, Induced, Abortifacient Agents, Nonsteroidal. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolAbortifacient AgentsAbortion, InducedAbortifacient Agents, NonsteroidalAbortifacient Agents, SteroidalHumansFemalePregnancyMifepristone

Substanzen

MifepristoneMisoprostolAbortifacient AgentsAbortifacient Agents, NonsteroidalAbortifacient Agents, Steroidal

Autor:innen und Institutionen

  • Barts and the London, School of Medicine and Dentistry (QMUL), London, UK.

ORCID-Profile: Poppy Sullivan, Sabthagi Sivathasan

Zitieren

APA

Sullivan, P., & Sivathasan, S. (2024). Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15352

Vancouver

Sullivan P, Sivathasan S. Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15352

BibTeX
@article{Sullivan2024,
  author = {Sullivan, Poppy and Sivathasan, Sabthagi},
  title = {Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15352}
}
Kostenlos starten →